Insight Molecular Diagnostics Inc. Deferred Income Tax Expense (Benefit)
Insight Molecular Diagnostics Inc. (IMDX) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2024-04-16
- Insight Molecular Diagnostics Inc. deferred income tax expense (benefit) for the quarter ending 2021-12-31 was $97.00K.
- Insight Molecular Diagnostics Inc. deferred income tax expense (benefit) for the quarter ending 2021-09-30 was $0.00.
- Insight Molecular Diagnostics Inc. deferred income tax expense (benefit) for the quarter ending 2021-06-30 was -$1.79M.
- Insight Molecular Diagnostics Inc. deferred income tax expense (benefit) for the quarter ending 2021-03-31 was -$7.56M.
- Insight Molecular Diagnostics Inc. deferred income tax expense (benefit) for fiscal 2023 was $0.00.
- Insight Molecular Diagnostics Inc. deferred income tax expense (benefit) for fiscal 2022 was $0.00.
- Insight Molecular Diagnostics Inc. deferred income tax expense (benefit) for fiscal 2021 was -$9.26M.
- Insight Molecular Diagnostics Inc. deferred income tax expense (benefit) for fiscal 2020 was -$1.25M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-16 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 | |||
| 2021-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $97.00K derived: sum of 2 quarters · filed 2023-04-12 | -$1.70M derived: sum of 3 quarters · filed 2023-04-12 | -$9.26M 10-K · filed 2023-04-12 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.79M derived: sum of 2 quarters · filed 2022-11-10 | -$9.36M 10-Q · filed 2022-11-10 | -$9.52M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$9.36M 10-Q · filed 2022-08-12 | -$9.52M derived: sum of 3 quarters · filed 2022-08-12 | -$9.52M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$7.56M 10-Q · filed 2022-05-12 | -$7.72M derived: sum of 2 quarters · filed 2022-05-12 | -$7.72M derived: sum of 3 quarters · filed 2022-05-12 | -$7.72M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$159.00K derived: sum of 2 quarters · filed 2022-03-11 | -$159.00K derived: sum of 3 quarters · filed 2022-03-11 | -$1.25M 10-K · filed 2022-03-11 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | -$1.09M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$1.09M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$1.09M 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |